After more than five decades of being in place, the federal monopoly on marijuana manufacturing ended earlier last week. Before its cessation, only the University of Mississippi was allowed by the Drug Enforcement Administration (“DEA”) to grow cannabis for study purposes.

The DEA had in the recent past announced that it would take action to end the monopoly and permit additional manufacturers. In May of last year, a number of companies received conditional approvals for their applications. Two of them — the Biopharmaceutical Research Company (“BRC”) and Groff North America Hemplex — revealed that they had recently received official registration from the DEA and had begun to grow and harvest the crop.

BRC concluded its first harvest in November 2021 and is now focused on its second harvest of marijuana plants under its DEA license. Gross North America Hemplex also concluded its first harvest towards the end of December 2021. The company is making arrangements with various Schedule I substance researchers to scale up the development of its produce.

Researchers state that this development represents a step forward, with the DEA beginning to oversee the production of research-grade marijuana on a new and much larger scale.

In an interview, Biopharmaceutical Research CEO George Hodgin stated that these steps had been made because of the work advocates of the marijuana community had done over the last few decades.

Advocates, health officials and legislators alike have been calling for expanded marijuana research, with most arguing that the current supply of government-grown cannabis for research was inadequate and that its products were chemically different from what consumers were purchasing in state-legal markets.

In a recent interview, Nora Volkow, director of NIDA, stated that researchers being allowed to access marijuana from retailers would be valuable as it would help to better understand the benefits and risks of what individuals were consuming in different states. In November 2021, President Joseph Biden signed an infrastructure legislation, which includes provisions that will provide researchers with this access.

Over in Congress, members are calling for the DEA to permit terminally ill patients to use psilocybin as an investigational therapy without fear of being federally prosecuted. Rep. Earl Blumenauer has been circulating a letter that highlights the existence of federal and state right-to-try laws that should allow eligible patients to access the psychedelic based on the promising potential it’s shown in various ongoing clinical trials.

This comes after a doctor in Washington State filed a lawsuit against the DEA for its refusal to allow him access to treat terminal patients using magic mushrooms.

The end of the cannabis production monopoly is likely to help the field of marijuana research, and the entire industry, including sector actors such as Simply Sonoma Inc., will benefit from that increased research.

NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma Inc. are available in the company’s newsroom at https://cnw.fm/Sonoma

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

American Cannabis Partners (“ACP”), a Jamaican experience canna-business innovator, has sought to establish a foothold in two key U.S. cannabis markets – California and Michigan – through a sustainable, vertically integrated model. The company now plans to expand into its third U.S. state in 2022 and its fourth in 2024. The company, which has acquired 12 cannabis cultivation and retail licenses, currently supplies approximately 80% of its whole flower product to third-party manufacturers and distributors; the remaining 20% is used in the manufacture and sale of its exclusive in-house brand, ZÜK. “In addition to its self-sustaining model, American Cannabis Partners has sought to differentiate its product within an increasingly commoditized cannabis market through the company’s unique adherence to Jamaican cultivation practices, which has led the company to produce some of the most sought-after flowers in the United States,” reads a recent article. The company further leverages its vertically integrated business model and a strict focus on acquiring its own real estate. “ACP finds itself in an enviable position to grow and develop its business at a time when the rest of the industry is subject to the vagaries of the global supply chain.”

To view the full article, visit https://cnw.fm/lKVYf

About American Cannabis Partners

American Cannabis Partners is a fully licensed, large scale and 100% organic cannabis cultivation company nationally headquartered in Trinity County of the Emerald Triangle. Guided by business professionals and cultivators, the company focuses on four industry segments: real estate, cultivation, medical research, and nonprofit groups. For both medical and recreational, American Cannabis Partners supplies multiple forms of raw product at wholesale prices for manufacturing, distribution and retail licenses. Its commodity pricing model enables stable profit margins for customers, aiding the company’s expansion into multiple states. For more information, visit the company’s website at www.ACPFarms.com.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

The past couple of years have been good for the cannabis industry. The industry managed to weather the coronavirus pandemic much better than other sectors, keeping most cannabis employees working and selling even more cannabis products than before the pandemic. However, the best developments have been on the legal side. Federal lawmakers are working on passing cannabis legislation at the federal level, and several states passed some form of cannabis legalization. Now that 2021 has finally run its course, let’s look at some of the most prominent marijuana reform accomplishments of the year.

Connecticut, which still has a completely green recreational market, has focused a great deal on social equity. The state’s newly enacted cannabis legalization bill led to the formation of the Social Equity Council, which is charged with molding Connecticut’s new recreational industry with social equity and diversity in mind.

Governor Ned Lamont highlighted the council’s efforts, stating that its primary duty would be to ensure equitable access to the lucrative cannabis market and mitigate some of the damage caused by the failed drug war. At the 15-person group’s first meeting, it rubber-stamped a list of geographical areas that were disproportionately affected by the decades-long war on drugs.

New Mexico also passed a cannabis law in 2021. Governor Michelle Lujan Grisham lauded the move, stating that it would greatly benefit the state’s economy. Legalizing cannabis in New Mexico will create thousands of new jobs — 11,000 to be exact, says Grisham. State officials began accepting license applications from businesses that would like to become licensed cannabis producers in August although sales still haven’t begun. In the meantime, adults aged 21 and older can possess up to two ounces of marijuana and grow up to six adult plants for personal use.

Commercial cannabis sales in New Mexico are expected to start this year while over in New Jersey, voters approved an amendment that would legalize cannabis consumption for adults 21 and older. New Jersey Governor Phil Murphy included the move in the state’s list of accomplishments for 2021. Commercial sales still haven’t kicked off as the state is still in the process of implementing the legalization. Home cultivation still isn’t allowed, but the governor has said that he is open to allowing people to cultivate cannabis at home for personal use while the state implements legalization.

Thanks to a near-infinite demand, the nascent cannabis industry is poised to see explosive growth over the next couple of years. Worth at least $20 billion in 2020, the sector is expected to grow at a compound annual growth rate of 32.04% to achieve a valuation of $197.74 billion by 2028.

As the sector grows in value, companies such as American Cannabis Partners, which position themselves well, are likely to take a bigger cut of the pie while others may end up being swallowed in the mergers and acquisitions which will accompany the maturation of the industry.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Harvard-trained forensic psychologist Dr. Kara Coe has released an update discussing her innovative use of cannabis as she works Navy SEALs dealing with post-traumatic stress disorder (“PTSD”). Coe has established a reputation for being one of the most successful interrogators in military history, and her well-respected PTSD treatment practice is located in Virginia Beach, home to the largest military bases in the world. According to the announcement, Coe treats almost 30 active-duty SEALs in weekly, no-cost group therapy meetings. She is known for using cannabis in her treatment efforts that, while unorthodox, have produced life-changing results. Coe points to significant empirical evidence that suggests marijuana is a safe and efficacious treatment for many symptoms of anxiety and depression and even cancer. She uses the substance during her practice, often inviting patients to enjoy a gummy before therapy to be used in conjunction with group or exposure treatments. “Anxiety disorders are easiest for me to address when the stressor is present,” said forensic psychologist Dr. Kara Coe in the press release. “It provides the most accurate functional analysis and allows me to experience the patient’s symptoms firsthand.”

To view the full press release, visit https://cnw.fm/4DYrn

About Dr. Kara Coe

Born and raised on the East Coast, Dr. Kara Coe knew early she wanted to help people. She received her doctorate in clinical psychology from the American School of Professional Psychology and completed residency, fellowship and postdoctoral training through a program at Harvard University. She has done work with forensic and military populations and has published a wide range of empirical literature, including articles related to parasuicidal behavior, psychopathy, interrogation, delinquency and transgendered patients. Coe is finishing a memoir depicting the internal struggle of soldiers she treated while working for the U.S. Army and NSA. She was licensed to practice in Washington, DC, and Virginia, and works with government agencies consulting on matters of national security. She recently gave up her licensure to provide free and confidential PTSD therapy to Navy SEALs. Her methods are believed to be unconventional but highly effective. In 2021, while helping to pass cannabis legislation in Virginia, Coe opened Queens Green Apothecary, an “Alice in Wonderland”-themed smoke shop, and Cannabar, a luxury smoking lounge. Coe also is involved with other CBD/THC products, including InkWell MetaFarm, products developed to heal burns and tattoos; equine hemp bedding; and a new line of ready-to-drinks (“RTDs”) that should be on shelves this fall.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.